Retraction. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
- PMID: 23211971
- PMCID: PMC3516686
- DOI: 10.1038/bjc.2012.497
Retraction. Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab
Retraction of
-
Pre-treatment levels of circulating free IGF-1 identify NSCLC patients who derive clinical benefit from figitumumab.Br J Cancer. 2011 Jan 4;104(1):68-74. doi: 10.1038/sj.bjc.6605972. Epub 2010 Nov 23. Br J Cancer. 2011. Retraction in: Br J Cancer. 2012 Dec 4;107(12):2024. doi: 10.1038/bjc.2012.497. PMID: 21102589 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
